Navigation Links
Intensity modulated proton therapy reduces need for feeding tubes by 50 percent
Date:9/25/2013

ATLANTA, GA A new study from researchers at The University of Texas MD Anderson Proton Therapy Center found that the use of feeding tubes in oropharyngeal carcinoma (OPC) cancer patients treated with intensity modulated proton therapy (IMPT) decreased by more than 50 percent compared to patients treated with intensity modulated radiation therapy (IMRT). This suggests that proton therapy may offer vital quality of life benefits for patients with tumors occurring at the back of the throat.

The results, presented today by the lead researcher, Steven J. Frank, M.D., associate professor of Radiation Oncology at MD Anderson at the American Society for Radiation Oncology's 55th Annual Meeting, also indicate that toxicity levels in OPC patients treated with IMPT are much lower than those treated with IMRT.

IMPT, one of the most advanced forms of proton therapy, delivers a precise dose of protons to tumors embedded in the "nooks and crannies" of the head and neck, including the base of tongue and tonsils. MD Anderson treated its first IMPT patient in 2011 and since approximately 150 patients, many with complex head and neck malignancies, have been treated with this form of proton therapy. Unlike IMRT, which destroys both cancerous and healthy cells, IMPT has the ability to destroy cancer cells while sparing surrounding healthy tissue from damage. Therefore, important quality of life outcomes such as neurocognitive function, vision, swallowing, hearing, taste and speech can be preserved in head and neck patients.

"IMPT is especially well-suited for patients with the most complicated tumors of the head and neck, precisely painting the protons onto the tumor layer by layer," said Frank. "In this way, the treatment team can confine the majority of the tumor-damaging energy to target areas and work to protect normal structures such as the oral cavity and brainstem."

OPC cancer develops in the part of the throat just behind the mouth.
'/>"/>

Contact: Agata Porter
agata.porter@gabbe.com
212-220-4444
University of Texas M. D. Anderson Cancer Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Intensity Modulated Radiation Therapy optimal for localized prostate cancer
2. Muscular Development Store Releases the Optimum Performance Workout for High Intensity Training
3. Viewing terrorist attacks on TV increases pain intensity -- Ben-Gurion U. researchers
4. Reduced intensity regimen prior to marrow transplant better for older leukemia patients
5. Pain Intensity May Help Differentiate 2 Skin Cancers
6. Smoking intensity and cancer markers predict seriousness of bladder cancer
7. Intensity modulated radiotherapy reduces side effects in patients with early breast cancer
8. Moderate-intensity walking timed just right might help protect against Type 2 diabetes
9. Proton therapy treatment preserves quality of life for men with prostate cancer
10. Horner Flooring to provide court for the MD Anderson Proton Therapy Showcase in Houston.
11. Penn Medicine study: Proton therapy cuts side effects for pediatric head and neck cancer patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... VA (PRWEB) May 07, 2015 Device Patent ... 27, 2015 — 11:00 a.m. – 12:30 p.m. EDT, ... up in expensive patent lawsuits and claims that waste their ... Many of these cases could be prevented if devicemakers better ... the latest court rulings and revisions to patent laws from ...
(Date:5/6/2015)... 06, 2015 RPS Revolution - a game ... tried and true Rock Paper Scissors game - is now ... that encourage storytelling and easy to learn rules from Rock ... an old favorite. RPS Revolution takes the best ... characters that are grouped in set of three called Trios. ...
(Date:5/6/2015)... May 06, 2015 Imprivata ® ... that CTO David Ting will lead a discussion about ... data security and user authentication challenges, during Citrix ... session will focus on the benefits of creating a ... care providers and patients can share information. It will ...
(Date:5/6/2015)... Qushanna Doby (20) was arrested for child neglect, after leaving ... while under the influence of Flakka, according to CBS ... CBS4’s Peter D’Oench records Doby distraught in a parking lot ... year old. The drug treatment center in Florida who found ... residents polled by CBS Miami express concern about the fate ...
(Date:5/6/2015)... May 06, 2015 The Canton Group is ... for the 6th annual charity softball game. The event ... & T Bank Stadium. Past years guests include Joe Flacco, ... are still on sale if you are interested ... local non-profit organizations, such as SOAR Baltimore and ...
Breaking Medicine News(10 mins):Health News:FDAnews Announces — Device Patent Law Changes: Six Key Areas of Concern Webinar, May 27, 2015 2Health News:FDAnews Announces — Device Patent Law Changes: Six Key Areas of Concern Webinar, May 27, 2015 3Health News:RPS Revolution Launches Kickstarter Campaign 2Health News:RPS Revolution Launches Kickstarter Campaign 3Health News:Imprivata to Lead Discussion about Patient and Provider Authentication Challenges and the Internet of Things in Healthcare during Citrix Synergy 2Health News:Flakka Induced Mother Abandons Baby, found by Florida Drug Treatment Center; New Video Released 2Health News:The Canton Group Sponsors Ravens Charity Softball Event 2Health News:The Canton Group Sponsors Ravens Charity Softball Event 3
... the opposite sex is looking at you depends on how masculine ... speculate that there may be an evolutionary advantage to quickly noticing ... how we determine whether someone else is looking at us or ... problem," says Benedict C. Jones, of the University of Aberdeen in ...
... gas bubbles and sound waves is to be developed at ... drugs to be delivered in small doses directly to tumours, ... If successful, the technique could easily be adapted for other ... cancer specialists from across the University to work on the ...
... the Iacocca Foundation announce today the completion of the Phase ... as the submission of all safety reports to the U.S. ... monitoring boards. Plans for the Phase II clinical study, which ... a treatment for people with existing type 1 diabetes, are ...
... ... as series co-host , ... Alpharetta, GA (Vocus) June 28, 2010 -- Physician recruiting firm LocumTenens.com ... channel for medical professionals broadcast on XM Satellite Radio channel 160, ReachMD.com, and the ...
... ... its effect on losing weight. It looks at how ephedrine products affect the body,s energy ... ... of an article that examines ephedrine HCL and its effects on weight loss. This article, ...
... Shopping for life insurance ... that matches their needs and stay within their budget., , ... Miami, Florida (PRWEB) June 28, 2010 -- An online life insurance firm is ... to pay for a term life insurance policy. With the introduction of the Select Your ...
Cached Medicine News:Health News:Reading the look of love 2Health News:Bursting bubbles with sound offers new treatments for cancer 2Health News:Bursting bubbles with sound offers new treatments for cancer 3Health News:Mass. General Hospital, Iacocca Foundation announce completion of Phase I diabetes trial 2Health News:LocumTenens.com to Sponsor New Series, Your Career In Healthcare, on ReachMD XM 160 2Health News:New Article Re-Examines Ephedrine HCL Products For Weight Loss 2Health News:Online Broker Lets Consumers Choose The Price of Life Insurance 2Health News:Online Broker Lets Consumers Choose The Price of Life Insurance 3
(Date:5/6/2015)... BEIJING, May 6, 2015 China Biologic Products, ... leading fully integrated plasma-based biopharmaceutical company in China, today ... of 2015. First Quarter 2015 Financial ... quarter of 2015 increased by 25.0% to $70.4 million ... , Gross profit increased by 18.9% to $45.9 ...
(Date:5/6/2015)... May 6, 2015 Asterias Biotherapeutics, Inc. ... the emerging field of regenerative medicine, today announced ... the investment community to review the clinical development ... cord injury on Friday, May 8, 2015. Topics ... and future planned clinical activities for AST-OPC1. ...
(Date:5/6/2015)... -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) today ... 2015.  The net loss and the loss from operations ... million, respectively, compared to $10.7 million and $8.8 million ... 31, 2015, Alexza had consolidated cash, cash equivalents, marketable ... "We continue to focus on ways in which to ...
Breaking Medicine Technology:China Biologic Reports Financial Results for the First Quarter of 2015 2China Biologic Reports Financial Results for the First Quarter of 2015 3China Biologic Reports Financial Results for the First Quarter of 2015 4China Biologic Reports Financial Results for the First Quarter of 2015 5China Biologic Reports Financial Results for the First Quarter of 2015 6China Biologic Reports Financial Results for the First Quarter of 2015 7China Biologic Reports Financial Results for the First Quarter of 2015 8China Biologic Reports Financial Results for the First Quarter of 2015 9China Biologic Reports Financial Results for the First Quarter of 2015 10China Biologic Reports Financial Results for the First Quarter of 2015 11China Biologic Reports Financial Results for the First Quarter of 2015 12China Biologic Reports Financial Results for the First Quarter of 2015 13China Biologic Reports Financial Results for the First Quarter of 2015 14China Biologic Reports Financial Results for the First Quarter of 2015 15China Biologic Reports Financial Results for the First Quarter of 2015 16China Biologic Reports Financial Results for the First Quarter of 2015 17China Biologic Reports Financial Results for the First Quarter of 2015 18Asterias Biotherapeutics to Host Investor Meeting to Review Clinical Development Strategy for AST-OPC1 in Spinal Cord Injury 2Asterias Biotherapeutics to Host Investor Meeting to Review Clinical Development Strategy for AST-OPC1 in Spinal Cord Injury 3Alexza Reports 2015 First Quarter Financial Results 2Alexza Reports 2015 First Quarter Financial Results 3Alexza Reports 2015 First Quarter Financial Results 4Alexza Reports 2015 First Quarter Financial Results 5Alexza Reports 2015 First Quarter Financial Results 6Alexza Reports 2015 First Quarter Financial Results 7Alexza Reports 2015 First Quarter Financial Results 8Alexza Reports 2015 First Quarter Financial Results 9Alexza Reports 2015 First Quarter Financial Results 10
... announced today the successful submission of an IND application ... clinical trials for their lead pyrimidinedione HIV inhibitor IQP-0410. ... first quarter of 2009. IQP-0410 is a novel small ... nonnucleoside reverse transcriptase inhibitor (NNRTI). The compound possesses a ...
... from prior U.S., U.K. and China TrialsSAN DIEGO, Jan. ... company targeting liver disease, today announced patient enrollment has ... trial that will study the Extracorporeal Liver Assist Device ... Failure (ALF) under three protocols. The study is open ...
Cached Medicine Technology:ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410 2ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 2ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 3
The Columbus microplate strip washer is for individual strips or whole plates.Programming and control are via an alphanumeric display. Up to 30 methods are stored for easy recall....
... The 1495-051 96PW washes all ... simultaneously and automatically. Separate wash ... throughput and excellent washing ability. ... the easily removable 96-channel head ...
Easy to use , Allow for a flexible washing , Uniform and efficient , Very robust and reliable , Adjustable to all well shapes , Rack included (not autoclavable) , Autoclavable at 121C , No e...
... SkanWasher 300 with ... system. Vacuum pressure and ... heights are adjustable. On-board ... configure 8 different programs. ...
Medicine Products: